Measurement of complement activation products on antigen arrays
OwnerJózsef Prechl, Krisztián Pappinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerJózsef Prechl, Krisztián Pappinventors
Estimating the term…
The basis of the present invention is that antigens on an antigen array can initiate complement activation both by antibody-dependent or -independent way. The systems and methods disclosed herein can be used in methods of diagnosing and monitoring particular autoimmune disorders and infections. The invention relates to a new diagnostic method, utilizing an antigen array for simultaneously identifying different antigens capable of activating the complement system, in a quantitative fashion; to multiplex immunoassays utilizing antigen arrays, and more particularly to systems, methods and kits for qualitative and quantitative detection of antigens activating complement in a biological sample, via the measurement of complement components deposited on antigen arrays. The invention employs the functional complement system in the biological sample tested, thereby the information gained relates to antigen recognition properties and functional consequences in the organism from which the sample was taken and relies on the ability of antigen recognition molecules, primarily antibodies to activate the complement system in the sample tested, upon binding to elements of an antigen array.
A method for the qualitative and quantitative analysis of complement activation on an antigen array, providing the antigen array with at least two antigens, detecting the covalently bound C3 and/or C4 fragments with a labelled detecting agent, characterised by the following steps:
A diagnostic kit for detecting disease associated changes in the immune profile, characterised by an antigen microarray as antigen array;
A method, termed two-dimensional immune profiling for the graphical representation and interpretation of data obtained by concurrent measurement of C3 and/or C4 deposition and antibody binding on an antigen microarray, wherein the relative value of bound C3 and/or C4 to bound antibody is used to characterize immune reactivity.
Dependencies are inferred from the claim text.